Exhaled 8-isoprostane as a prognostic marker in sarcoidosis. A short term follow-up

BMC Pulmonary Medicine

Volumn 10, Issue , 2010, Pages

  Piotrowski, Wojciech J ^a   Kurmanowska, Zofia ^a   Antczak, Adam ^a   Marczak, Jerzy ^a   Górski, Paweł ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; BIOLOGICAL MARKER; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; DRUG DERIVATIVE; PROSTAGLANDIN F2 ALPHA;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPIRED AIR; FEMALE; FOLLOW UP; HUMAN; LUNG FUNCTION TEST; LUNG SARCOIDOSIS; MALE; PROGNOSIS; REMISSION; RISK FACTOR; SYMPTOM; THERAPY EFFECT; THORAX RADIOGRAPHY; CASE CONTROL STUDY; DISEASE COURSE; EXHALATION; HOSPITALIZATION; METABOLISM; MIDDLE AGED; SARCOIDOSIS;

ADULT; BIOLOGICAL MARKERS; CALCIUM; CASE-CONTROL STUDIES; DINOPROST; DISEASE PROGRESSION; EXHALATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REMISSION, SPONTANEOUS; RESPIRATORY FUNCTION TESTS; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX;

EID: 77951220442     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-10-23     Document Type: Article

References (20)

1. American Thoracic Society European Respiratory Society: World Association of Sarcoidosis and Other Granulomatous Disorders. Statement on sarcoidosis. Am J Respir Crit Care Med 1999, 160:736-755. American Thoracic Society.
2. Baughman RP, Judson MA, Teirstein A, et al. Presenting characteristics as predictors of duration of treatment in sarcoidosis. Q J Med 2006, 99:307-315.
3. Behr J, Maier K, Degenholb B, Krombach F, Vogelmeier C. Antioxidative and clinical effects of high-dose N-acetylcysteine in fibrosing alveolitis. Adjunctive therapy to maintenance immunosuppression. Am J Respir Crit Care Med 1997, 156:1897-1901.
4. Cassatella MA, Berton G, Agostini C, et al. Generation of superoxide anion by alveolar macrophages in sarcoidosis: evidence for the activation of the oxygen metabolism in patients with high-intensity alveolitis. Immunology 1989, 66:451-458. 1385236, 2539325.
5. Lenz A-G, Costabel U, Maier KL. Oxidized BAL fluid proteins in patients with interstitial lung diseases. Eur Respir J 1996, 9:307-312. 10.1183/09031936.96.09020307, 8777969.
6. Morrow JD, Frei B, Atkinson W, et al. Increase in circulating products of lipid peroxidation (F2-isoprostane) in smokers. Smoking as a cause of oxidative damage. N Eng J Med 1995, 332:1198-1203.
7. Montuschi P, Ciabattoni G, Paredi P, et al. 8-isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 1998, 158:1524-1527.
8. Psathakis K, Papatheodorou G, Plataki M, et al. 8-Isoprostane, a marker of oxidative stress, is increased in the expired breath condensate of patients with pulmonary sarcoidosis. Chest 2004, 125:1005-1011. 10.1378/chest.125.3.1005, 15006961.
9. Piotrowski WJ, Antczak A, Marczak J, et al. Eicosanoids in exhaled breath condensate and BAL fluid of patients with sarcoidosis. Chest 2007, 132:589-596. 10.1378/chest.07-0215, 17573522.
10. Horvath I, Hunt J, Barnes PJ, . on behalf of the ATS/ERS Task Force on Exhaled Breath Condensate Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005, 26:523-548. 10.1183/09031936.05.00029705, 16135737, on behalf of the ATS/ERS Task Force on Exhaled Breath Condensate.
11. Standardization of spirometry American Thoracic Society. Am J Respir Crit Care Med 1995, 152:1107-1136. 1994 update, Standardization of spirometry.
12. Standardized lung function testing Official statement of the European Respiratory Society. Eur Respir J 1993, 16(suppl):1-100. Standardized lung function testing.
13. British Thoracic Society guidelines on diagnostic flexible bronchoscopy British Thoracic Society Bronchoscopy Guidelines Committee, a Subcommittee of the Standards of Care Committee of the British Thoracic Society. Thorax 2001, 56(suppl I):i1-i21. 1765978, 11158709, British Thoracic Society guidelines on diagnostic flexible bronchoscopy.
14. Antczak A, Montuschi P, Kharitonov S, et al. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma. Am J Respir Crit Care Med 2002, 166:301-306. 10.1164/rccm.2101021, 12153961.
15. Baraldi E, Ghiro L, Piovan V, et al. Increased exhaled 8-isoprostane in childhood asthma. Chest 2003, 124:25-31. 10.1378/chest.124.1.25, 12853498.
16. Baraldi E, Carraro S, Alinovi R, et al. Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 2003, 58:505-509. 10.1136/thorax.58.6.505, 1746712, 12775861.
17. Shorr AF, Torrington KG, Hnatiuk OW. Endobronchial involvement and airway hyperreactivity in patients with sarcoidosis. Chest 2001, 120:881-886. 10.1378/chest.120.3.881, 11555524.
18. Piotrowski WJ, Kurmanowska Z, Antczak A, et al. Superoxide anion production by bronchoalveolar lavage cells in relation to cellular composition and lung function in sarcoidosis and chronic bronchitis. Pol Arch Med Wewn 2009, 119:777-784.
19. Roży A, Czerniawska J, Ste{ogonek}pniewska A, et al. Inflammatory markers in the exhaled breath condensate of patients with pulmonary sarcoidosis. J Physiol Pharmacol 2006, 57(supp 4):335-400.
20. Baughman RP, Drent M, Kavuru M, et al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006, 174:795-802. 10.1164/rccm.200603-402OC, 16840744.